The neurikinin 1 (NK1) receptor is one of subtypes of the tachykinin receptors, and it is of interest in pathophysiology of psychiatric disorders, e.g., depression. [18F]FE-SPA-RQ was recently developed as a radioligand for the measurement of NK1 receptor imaging with positron emission tomography (PET) [1]. In this study, NK1 receptor was visualized in human brain using this radioligand with PET and quantified by several quantification methods.NeuroReceptor Mapping 200
Introduction: Norepinephrine transporters are of interest in pathophysiology of several psychiatric ...
Netupitant is a new, selective NK1 receptor antagonist under development for the prevention of chemo...
Substance P (SP) has been known to trigger biological responses by linking to NK 1 receptors. The pr...
18F-fluoroethyl-SPA-RQ (18F-FE-SPA-RQ) was recently devel-oped as a radioligand for themeasurement o...
Central substance P receptors, termed NK-1 receptors, have been considered as therapeutic targets in...
PURPOSE: NK1 receptors have been implicated in various neuropsychiatric and other disorders. R116301...
Emerging evidence suggests neurokinin-1 receptors (NK1Rs) may be altered in depression and NK1R anta...
The neurokinin-1 (NK1) receptor is abundantly expressed in the fear circuitry of the brain, includin...
The neurokinin 1 receptor (NK-1R) is the main receptor for the tachykinin family of peptides. Substa...
The neurokinin-1 (NK1) receptor is abundantly expressed in the fear circuitry of the brain, includin...
There is a substantial interest in the development of NK1 substance P antagonists as potential treat...
The Neurokinin 1 receptor (NK1R) is associated with neurogenic inflammation and nociceptive transmis...
Neurokinin-1 receptor (NK1R), or substance P receptor, is a G protein-coupled receptor (GPCR) that t...
The type 1 neurokinin receptor (NK1R) antagonist aprepitant and its i.v. prodrug fosaprepitant have ...
Norepinephrine transporters are of interest in pathophysiology of several psychiatric disorders, and...
Introduction: Norepinephrine transporters are of interest in pathophysiology of several psychiatric ...
Netupitant is a new, selective NK1 receptor antagonist under development for the prevention of chemo...
Substance P (SP) has been known to trigger biological responses by linking to NK 1 receptors. The pr...
18F-fluoroethyl-SPA-RQ (18F-FE-SPA-RQ) was recently devel-oped as a radioligand for themeasurement o...
Central substance P receptors, termed NK-1 receptors, have been considered as therapeutic targets in...
PURPOSE: NK1 receptors have been implicated in various neuropsychiatric and other disorders. R116301...
Emerging evidence suggests neurokinin-1 receptors (NK1Rs) may be altered in depression and NK1R anta...
The neurokinin-1 (NK1) receptor is abundantly expressed in the fear circuitry of the brain, includin...
The neurokinin 1 receptor (NK-1R) is the main receptor for the tachykinin family of peptides. Substa...
The neurokinin-1 (NK1) receptor is abundantly expressed in the fear circuitry of the brain, includin...
There is a substantial interest in the development of NK1 substance P antagonists as potential treat...
The Neurokinin 1 receptor (NK1R) is associated with neurogenic inflammation and nociceptive transmis...
Neurokinin-1 receptor (NK1R), or substance P receptor, is a G protein-coupled receptor (GPCR) that t...
The type 1 neurokinin receptor (NK1R) antagonist aprepitant and its i.v. prodrug fosaprepitant have ...
Norepinephrine transporters are of interest in pathophysiology of several psychiatric disorders, and...
Introduction: Norepinephrine transporters are of interest in pathophysiology of several psychiatric ...
Netupitant is a new, selective NK1 receptor antagonist under development for the prevention of chemo...
Substance P (SP) has been known to trigger biological responses by linking to NK 1 receptors. The pr...
Add to ORKG